What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q4 2022?

164 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q4 2022. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 73,478,005
Share change: +6,663,175
Total reported value: $457,748,937
Put/Call ratio: 24%
Price per share: $6.23
Number of holders: 164
Value change: +$39,215,603
Number of buys: 95
Number of sells: 63

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 29664W105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WASATCH ADVISORS LP	13F	Company	2.9%	7,463,016	$50,002,000	—	30 Sep 2022	13F
Deep Track Capital, LP	13F	Company	2.2%	5,636,587	$37,765,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	1.8%	4,558,644	$30,542,000	—	30 Sep 2022	13F
Meditor Group Ltd	13F	Company	1.7%	4,468,835	$29,941,000	—	30 Sep 2022	13F
Bellevue Group AG	13F	Company	1.6%	4,225,264	$28,309,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	1.6%	4,038,525	$27,059,000	—	30 Sep 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	2,788,300	$18,682,000	—	30 Sep 2022	13F
Ikarian Capital, LLC	13F	Company	0.82%	2,131,147	$14,278,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.67%	1,723,175	$11,545,000	—	30 Sep 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	0.67%	1,719,831	$11,523,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	0.59%	1,533,148	$10,272,000	—	30 Sep 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.55%	1,430,001	$9,581,000	—	30 Sep 2022	13F
Woodline Partners LP	13F	Company	0.46%	1,195,705	$8,011,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.44%	1,127,580	$7,554,000	—	30 Sep 2022	13F
Rhenman & Partners Asset Management AB	13F	Company	0.35%	900,000	$7,317,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.42%	1,084,300	$7,265,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.41%	1,068,438	$7,159,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0.39%	1,009,773	$6,766,000	—	30 Sep 2022	13F
BIOTECH TARGET N V	3/4/5	10%+ Owner	— class O/S missing	4,477,964	$5,575,065	—	24 May 2021	3/4/5
Schonfeld Strategic Advisors LLC	13F	Company	0.31%	803,069	$5,381,000	—	30 Sep 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.31%	795,671	$5,331,000	—	30 Sep 2022	13F
Walleye Capital LLC	13F	Company	0.27%	698,343	$4,679,000	—	30 Sep 2022	13F
Altium Capital Management LLC	13F	Company	0.26%	659,869	$4,421,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.23%	582,008	$3,900,000	—	30 Sep 2022	13F
MARSHALL WACE, LLP	13F	Company	0.22%	560,987	$3,758,000	—	30 Sep 2022	13F
J. Goldman & Co LP	13F	Company	0.21%	553,010	$3,705,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.2%	514,738	$3,448,000	—	30 Sep 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.19%	500,000	$3,350,000	—	30 Sep 2022	13F
Invesco Ltd.	13F	Company	0.19%	496,516	$3,327,000	—	30 Sep 2022	13F
Commodore Capital LP	13F	Company	0.18%	467,468	$3,132,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	465,799	$3,121,000	—	30 Sep 2022	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.16%	419,918	$2,813,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.16%	400,836	$2,686,000	—	30 Sep 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.14%	364,951	$2,445,000	—	30 Sep 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.14%	361,052	$2,419,000	—	30 Sep 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.14%	351,039	$2,352,000	—	30 Sep 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.13%	332,123	$2,225,000	—	30 Sep 2022	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	314,095	$2,104,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.12%	301,359	$2,019,000	—	30 Sep 2022	13F
Parkman Healthcare Partners LLC	13F	Company	0.11%	296,381	$1,986,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.11%	286,700	$1,921,000	—	30 Sep 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.11%	274,425	$1,838,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.11%	272,406	$1,825,000	—	30 Sep 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.1%	263,058	$1,762,000	—	30 Sep 2022	13F
Monaco Asset Management SAM	13F	Company	0.1%	260,000	$1,742,000	—	30 Sep 2022	13F
Pentwater Capital Management LP	13F	Company	0.1%	255,092	$1,709,000	—	30 Sep 2022	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.09%	242,616	$1,626,000	—	30 Sep 2022	13F
TENOR CAPITAL MANAGEMENT Co., L.P.	13F	Company	0.07%	185,838	$1,245,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.07%	169,826	$1,138,000	—	30 Sep 2022	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.07%	168,552	$1,129,000	—	30 Sep 2022	13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2022

As of 31 Dec 2022, Esperion Therapeutics, Inc. - COM (ESPR) was held by 164 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,478,005 shares. The largest 10 holders included WASATCH ADVISORS INC, BlackRock Inc., Meditor Group Ltd, Bellevue Group AG, VANGUARD GROUP INC, Deep Track Capital, LP, Balyasny Asset Management LLC, BRAIDWELL LP, Point72 Asset Management, L.P., and MILLENNIUM MANAGEMENT LLC. This page lists 164 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

143

Q4 2022 holders

164

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.